Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
---|---|---|---|---|---|---|---|---|
Feb 04, 2022 | Feb 07, 2022 | Drygin Denis Chief Scientific Officer | Buy | Regulus Therapeutics Inc. | RGLS | $0.23 | $5,362 | +50.00% |
- 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.